Dyne Therapeutics, Inc. logo DYN - Dyne Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 11
HOLD 2
SELL 0
STRONG
SELL
0
| PRICE TARGET: $35.50 DETAILS
HIGH: $47.00
LOW: $24.00
MEDIAN: $35.50
CONSENSUS: $35.50
UPSIDE: 48.97%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Revenue
Revenue 0 0 0 0 0 0 0 0 506 1,366 842 1,466 3 3 1,585 2,323 2,468 3,549 3,103
Cost of Revenue 2.0 2.2 2.5 0 0 0.7 0.3 0.0 2,932 2,281 2,028 1,145 1,145 268 963 1,181 1,194 1,853 2,013
Gross Profit (2.0) (2.2) (2.5) 0 0 (0.7) (0.3) (0.0) (2,426) (915) (1,186) 321 (1,142) (265) 622 1,142 1,274 1,696 1,090
Operating Expenses
R&D Expenses 398.3 281.4 210.8 142.8 121.3 45.2 11.0 4.3 0 0 0 0 0 0 0 0 0 0 0
SG&A Expenses 69.9 62.5 31.4 28.2 28.7 12.7 2.8 0.5 189 161 128 (97) 97 (22) 135 163 (159) (157) (203)
Other Expenses 0 (2.2) (2.5) 0 0 0 0 (0.0) 0 0 0 (211) 0 (59) 0 0 (360) (337) 0
Operating Expenses 466.1 341.6 239.7 171.0 150.0 57.9 13.8 4.8 189 161 128 (308) 97 (81) 135 163 (519) (494) (203)
Operating Income
Operating Income (468.2) (343.9) (242.2) (171.0) (150.0) (58.6) (13.8) (4.8) (412) (640) 64 (318) (318) 714 (236) (11) (834) 709 605
Interest Expense 6.2 0 0 2.9 0 0.4 0 0.0 616 625 546 67 97 0 357 363 415 427 384
Interest Income 29.9 26.9 7.6 2.9 0.7 0.1 0.3 0.0 0 0 0 0 0 0 0 0 0 0 0
Profitability
EBITDA (438.0) (315.2) (233.5) (163.5) (148.2) (58.3) (14.6) (4.8) 949 106 736 292 150 113 (1,574) 734 (173) 902 830
EBIT (440.0) (317.4) (235.9) (165.2) (149.3) (59.0) (14.9) (4.8) 78 (664) 119 (201) (320) 0 (1,920) 128 (940) 673 651
Income Before Tax (446.2) (317.4) (235.9) (168.1) (149.3) (59.4) (14.9) (4.8) (538) (1,289) (427) (268) (417) 87 (2,277) (235) (1,355) 246 267
Income Tax Expense 0 0 0 0 0 (0.7) 0 (0.0) (610) (45) (474) 117 (58) 0 (632) 197 315 (75) (151)
Net Income (446.2) (317.4) (235.9) (168.1) (149.3) (58.7) (13.5) (4.8) 76 (1,240) 50 (67) (356) 87 (1,645) (234) (1,262) 174 264
Per Share Data
EPS (Basic) -3.47 -3.37 -3.95 -3.23 -2.93 -1.24 -0.30 -0.47 0.47 -9.61 0.40 -0.53 -3.56 0.87 -13.48 -1.95 -1.25 0.20 0.25
EPS (Diluted) -3.47 -3.37 -3.95 -3.23 -2.93 -1.24 -0.30 -0.47 0.47 -9.61 0.40 -0.53 -3.56 0.87 -13.48 -1.93 -1.25 0.20 0.25
Shares Outstanding 128.4 94.1 59.7 52.0 50.9 47.3 45.4 10.3 162 129 125 126 100 100 122 120 1,009.6 870 1,042.2
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Current Assets
Cash & Cash Equivalents 893.4 435.4 121.6 172.1 200.8 300.9 14.6 8.1 365 1,776 505 1,870 843 348 396 291 471 693 328
Short-Term Investments 217.2 206.8 1.5 83.9 175.7 44.5 0 0 32 130 100 78 25 13 69 106 78 87 104
Net Receivables 0 0 0 0 0 0 0 0 513 386 402 270 420 108 6 230 212 340 426
Inventory 0 0 0 0 0 0 0 0 445 445 597 208 181 101 57 121 141 184 199
Other Current Assets 16.0 17.0 6.3 9.6 0.4 0 0 0 169 250 341 248 216 473 144 1,496 1,136 1,499 606
Total Current Assets 1,126.6 659.3 129.4 265.6 382.4 349.1 14.8 8.2 1,524 2,987 1,945 2,674 1,685 1,043 672 2,244 2,038 2,803 1,663
Non-Current Assets
Property, Plant & Equipment 44.8 30.0 33.4 38.4 41.0 1.9 1.5 0.1 8,884 7,121 8,347 3,255 3,315 3,022 3,334 6,273 9,071 10,869 10,689
Goodwill 0 0 0 0 0 0 0 0 772 799 797 0 0 0 0 0 0 433 438
Intangible Assets 0 0 0 0 0 0 0 0 25 38 102 27 108 271 0 141 380 437 497
Long-Term Investments 0 0 0 0 0 0 0 0 26 16 18 2 11 0 0 0 0 0 0
Other Non-Current Assets 15.6 1.9 2.3 2.3 2.3 2.3 0.2 0 (31) 1,665 330 5,254 72 181 116 1,343 (536) (329) (66)
Total Non-Current Assets 60.4 32.0 35.7 40.7 43.3 4.2 1.7 0.1 10,247 10,066 9,594 8,558 3,606 3,492 3,455 7,769 8,915 11,410 11,558
Total Assets 1,187.0 691.2 165.1 306.3 425.7 353.3 16.4 8.3 11,771 13,053 11,539 11,232 5,291 4,535 4,127 10,013 10,953 14,213 13,221
Current Liabilities
Account Payables 8.1 6.6 22.9 5.3 4.0 3.4 1.3 0.5 367 332 292 216 329 112 15 134 181 303 292
Short-Term Debt 5.0 4.8 0 0 0 0 0 0 105 201 83 31 13 29 4 148 807 64 51
Deferred Revenue 0 0 0 0 0 0 0 0 7 5 29 20 100 95 5 12 6 6 45
Other Current Liabilities 37.5 17.8 0 0 0 0 0.6 0.0 570 378 408 414 279 111 135 1,271 853 1,329 611
Total Current Liabilities 50.6 42.3 51.1 28.1 28.7 11.0 2.4 0.7 1,049 916 812 681 721 347 159 1,565 1,847 1,702 999
Non-Current Liabilities
Long-Term Debt 15.3 0 0 0 0 0 0 3.4 8,328 8,778 7,206 7,075 1,979 1,386 584 4,426 807 64 51
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 7 5 29 20 100 95 5 641 0 0 0
Other Non-Current Liabilities 148.9 0 0 0 0 0 0.0 9.1 146 170 183 217 178 257 145 336 359 500 388
Total Non-Current Liabilities 164.2 19.1 22.7 25.9 28.7 0 0.0 12.4 8,481 8,953 7,418 7,312 2,257 1,738 734 5,403 1,166 564 439
Total Liabilities 214.8 61.4 73.8 54.0 57.5 11.0 2.4 13.1 9,870 11,011 8,618 8,209 3,081 2,032 3,015 7,267 7,974 9,728 8,692
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1 1 1 1 1 1 1 1 6 5 5
Retained Earnings (1,396.1) (949.9) (632.5) (396.6) (228.5) (79.2) (19.7) (4.9) (1,851) (1,927) (686) (736) (463) (107) (4,841) (3,196) 0 0 0
Accumulated Other Comprehensive Income 0.5 0.0 0 (0.6) (0.3) (0.0) 0 (0.0) 32 21 19 20 58 11 (53) (53) (150) (215) (25)
Total Stockholders' Equity 972.1 629.8 91.3 252.4 368.2 342.4 14.0 (4.9) 1,901 2,042 2,921 3,023 2,210 2,503 1,112 2,746 2,902 4,515 4,506
Total Liabilities & Equity 1,187.0 691.2 165.1 306.3 425.7 353.3 16.4 8.3 11,771 13,053 11,539 11,232 5,291 4,535 4,127 10,013 10,953 14,213 13,221
Debt Metrics
Total Debt 20.3 24.0 27.4 30.5 32.6 0 0 3.4 8,433 8,979 7,289 7,106 1,992 1,415 588 4,574 1,614 128 102
Net Debt (873.1) (411.5) (94.2) (141.7) (168.2) (300.9) (14.6) (4.7) 8,068 7,203 6,784 5,236 1,149 1,067 192 4,283 1,143 (565) (226)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Operating Activities
Net Income (446.2) (317.4) (235.9) (168.1) (149.3) (59.4) (14.9) (4.8) 76 (1,240) 50 (67) (356) 87 (1,645) (234) (1,262) 174 264
Depreciation & Amortization 2.0 (1.9) 1.7 1.7 1.1 0.7 0.3 0.0 867 766 614 292 467 26 346 408 359 376 333
Stock-Based Compensation 45.9 45.9 20.0 15.2 17.5 6.6 0.0 0.0 0 0 0 0 0 0 0 0 0 0 0
Change in Working Capital (3.4) (19.5) 26.3 (5.4) 9.3 5.1 1.4 0.6 (1,596) 938 (860) 1,029 268 183 (166) 488 (910) 437 522
Other Non-Cash Items (1.5) 0.6 (0.2) 3.0 (0.7) 0.5 1.3 0.0 584 136 (215) (1,336) (275) (340) 813 (434) 2,384 (741) (471)
Operating Cash Flow (403.2) (292.4) (188.2) (153.6) (119.6) (46.5) (11.8) (4.2) 585 676 94 (62) 175 (44) (20) 423 135 319 341
Investing Activities
Capital Expenditure (1.9) (2.4) (0.7) (3.1) (3.6) (1.2) (1.6) (0.1) (224) (326) (275) 0 (98) 0 (242) (333) 0 0 0
Acquisitions 0 0 0 0.0 0.0 0 0 0 (3,319) 0 (6,078) 0 234 0 0 0 0 0 (128)
Purchases of Investments (180.5) (317.4) (44.3) (121.2) (236.7) (44.5) 0 0 0 0 (250) 0 0 0 0 (508) 0 0 0
Sales/Maturities of Investments 172.5 115.7 128.3 211.4 102.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Investing Activities (18.8) 0.0 0 (0.0) (0.0) 0 0 0 784 (1,821) 5,409 (5,148) 338 348 (12) 307 251 (102) (689)
Investing Cash Flow (28.8) (204.1) 83.3 87.2 (137.9) (45.7) (1.6) (0.1) (2,759) (2,147) (1,194) (5,148) 474 348 (254) (534) 251 (102) (817)
Financing Activities
Net Debt Issuance 147.7 0 0 0 0 (0.1) 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 (250) (1,870) (843) (348) (396) (291) 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 36.8 2.0 0.5 0.6 (0.4) 0 5 (1,299) 2,742 (265) 5,210 (154) (328) 379 (69) (608) 148 433
Financing Cash Flow 890.3 809.9 54.3 37.4 157.8 380.7 20.0 12.4 (1,299) 2,742 (265) 5,210 (154) (328) 379 (69) (608) 148 433
Cash Position
Net Change in Cash 458.3 313.4 (50.5) (29.1) (99.6) 288.5 6.5 12.4 (3,473) 1,271 (1,365) 0 495 (107) 105 (180) (222) 365 (43)
Cash at Beginning 437.4 123.9 174.5 203.5 303.2 14.6 8.1 (4.3) 3,838 505 1,870 1,870 348 455 291 471 693 328 371
Cash at End 895.7 437.4 123.9 174.5 203.5 303.2 14.6 8.1 365 1,776 505 1,870 843 348 396 291 471 693 328
Free Cash Flow (405.1) (294.7) (188.9) (156.7) (123.2) (47.7) (13.5) (4.3) 361 350 (181) (62) 77 (44) (262) 90 135 319 341
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Income Statement
Revenue 0 0 0 0 0 0 0 0 506 1,366 842 1,466 3 3 1,585 2,323 2,468 3,549 3,103
Gross Profit (2.0) (2.2) (2.5) 0 0 (0.7) (0.3) (0.0) (2,426) (915) (1,186) 321 (1,142) (265) 622 1,142 1,274 1,696 1,090
Operating Income (468.2) (343.9) (242.2) (171.0) (150.0) (58.6) (13.8) (4.8) (412) (640) 64 (318) (318) 714 (236) (11) (834) 709 605
Net Income (446.2) (317.4) (235.9) (168.1) (149.3) (58.7) (13.5) (4.8) 76 (1,240) 50 (67) (356) 87 (1,645) (234) (1,262) 174 264
EPS (Diluted) -3.47 -3.37 -3.95 -3.23 -2.93 -1.24 -0.30 -0.47 0.47 -9.61 0.40 -0.53 -3.56 0.87 -13.48 -1.93 -1.25 0.20 0.25
Balance Sheet
Cash & Equivalents 893.4 435.4 121.6 172.1 200.8 300.9 14.6 8.1 365 1,776 505 1,870 843 348 396 291 471 693 328
Total Assets 1,187.0 691.2 165.1 306.3 425.7 353.3 16.4 8.3 11,771 13,053 11,539 11,232 5,291 4,535 4,127 10,013 10,953 14,213 13,221
Total Debt 20.3 24.0 27.4 30.5 32.6 0 0 3.4 8,433 8,979 7,289 7,106 1,992 1,415 588 4,574 1,614 128 102
Stockholders' Equity 972.1 629.8 91.3 252.4 368.2 342.4 14.0 (4.9) 1,901 2,042 2,921 3,023 2,210 2,503 1,112 2,746 2,902 4,515 4,506
Cash Flow
Operating Cash Flow (403.2) (292.4) (188.2) (153.6) (119.6) (46.5) (11.8) (4.2) 585 676 94 (62) 175 (44) (20) 423 135 319 341
Capital Expenditure (1.9) (2.4) (0.7) (3.1) (3.6) (1.2) (1.6) (0.1) (224) (326) (275) 0 (98) 0 (242) (333) 0 0 0
Free Cash Flow (405.1) (294.7) (188.9) (156.7) (123.2) (47.7) (13.5) (4.3) 361 350 (181) (62) 77 (44) (262) 90 135 319 341